Across both groups, eGFR declined by 6.76% in COPD and 3.16% in SSc-ILD, while the albumin-to-creatinine ratio (ACR) increased by 21% in COPD and by 6.7% in SSc-ILD. This evidence concerns the gene ALB and systemic sclerosis.